

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.40391066 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.40391066 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.45150798 |
| 4 | amyloid precursor protein catabolic process (GO:0042987) | 5.00205070 |
| 5 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.38178385 |
| 6 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.27809797 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06641664 |
| 8 | proline biosynthetic process (GO:0006561) | 3.82330975 |
| 9 | protein localization to endosome (GO:0036010) | 3.81569554 |
| 10 | sterol catabolic process (GO:0016127) | 3.76313904 |
| 11 | cholesterol catabolic process (GO:0006707) | 3.76313904 |
| 12 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.75340944 |
| 13 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.71674389 |
| 14 | negative regulation of cell size (GO:0045792) | 3.46879892 |
| 15 | apoptotic process involved in morphogenesis (GO:0060561) | 3.44361991 |
| 16 | Golgi transport vesicle coating (GO:0048200) | 3.43832708 |
| 17 | COPI coating of Golgi vesicle (GO:0048205) | 3.43832708 |
| 18 | mannose metabolic process (GO:0006013) | 3.42839945 |
| 19 | glycosphingolipid catabolic process (GO:0046479) | 3.39768792 |
| 20 | regulation of early endosome to late endosome transport (GO:2000641) | 3.37323799 |
| 21 | amyloid precursor protein metabolic process (GO:0042982) | 3.31858616 |
| 22 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.30632182 |
| 23 | exocrine pancreas development (GO:0031017) | 3.28568716 |
| 24 | pentose metabolic process (GO:0019321) | 3.23813677 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.19884982 |
| 26 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.16934782 |
| 27 | regulation of translational fidelity (GO:0006450) | 3.15789593 |
| 28 | valine metabolic process (GO:0006573) | 3.14918174 |
| 29 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.14689316 |
| 30 | ribosomal small subunit biogenesis (GO:0042274) | 3.11982719 |
| 31 | signal peptide processing (GO:0006465) | 3.08308801 |
| 32 | pinocytosis (GO:0006907) | 3.07665341 |
| 33 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.07536681 |
| 34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.07294148 |
| 35 | rRNA transcription (GO:0009303) | 3.06114789 |
| 36 | response to peptidoglycan (GO:0032494) | 3.04987636 |
| 37 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.01480925 |
| 38 | vitamin transmembrane transport (GO:0035461) | 3.00940724 |
| 39 | glycolipid catabolic process (GO:0019377) | 2.95814891 |
| 40 | cellular response to arsenic-containing substance (GO:0071243) | 2.94731640 |
| 41 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.93998828 |
| 42 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.92521517 |
| 43 | regulation of gamma-delta T cell activation (GO:0046643) | 2.92491809 |
| 44 | amino sugar catabolic process (GO:0046348) | 2.88730045 |
| 45 | L-serine transport (GO:0015825) | 2.87253528 |
| 46 | L-phenylalanine metabolic process (GO:0006558) | 2.86240559 |
| 47 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.86240559 |
| 48 | L-phenylalanine catabolic process (GO:0006559) | 2.86198942 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.86198942 |
| 50 | response to thyroid hormone (GO:0097066) | 2.84851931 |
| 51 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.82516415 |
| 52 | urea cycle (GO:0000050) | 2.81079029 |
| 53 | serine transport (GO:0032329) | 2.80869018 |
| 54 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.79421835 |
| 55 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.78688613 |
| 56 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.78227329 |
| 57 | mitochondrial fusion (GO:0008053) | 2.77376298 |
| 58 | lymph vessel development (GO:0001945) | 2.77320112 |
| 59 | barbed-end actin filament capping (GO:0051016) | 2.76077497 |
| 60 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.74374385 |
| 61 | regulation of superoxide anion generation (GO:0032928) | 2.73849989 |
| 62 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.72397185 |
| 63 | T cell migration (GO:0072678) | 2.70527986 |
| 64 | protein maturation by protein folding (GO:0022417) | 2.66990645 |
| 65 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.64906469 |
| 66 | response to acidic pH (GO:0010447) | 2.64341157 |
| 67 | outflow tract septum morphogenesis (GO:0003148) | 2.62808380 |
| 68 | mammary gland epithelial cell differentiation (GO:0060644) | 2.62762549 |
| 69 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.60566287 |
| 70 | pyrimidine nucleoside salvage (GO:0043097) | 2.60518869 |
| 71 | pyrimidine-containing compound salvage (GO:0008655) | 2.60518869 |
| 72 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.60018447 |
| 73 | mast cell activation (GO:0045576) | 2.59567604 |
| 74 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.58456393 |
| 75 | negative regulation of cell killing (GO:0031342) | 2.57444199 |
| 76 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.57444199 |
| 77 | pentose-phosphate shunt (GO:0006098) | 2.57305278 |
| 78 | mast cell activation involved in immune response (GO:0002279) | 2.57191018 |
| 79 | mast cell degranulation (GO:0043303) | 2.57191018 |
| 80 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.55814924 |
| 81 | short-chain fatty acid metabolic process (GO:0046459) | 2.55314239 |
| 82 | tooth mineralization (GO:0034505) | 2.54649872 |
| 83 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.54495123 |
| 84 | cellular protein complex localization (GO:0034629) | 2.53907713 |
| 85 | GDP-mannose metabolic process (GO:0019673) | 2.52640731 |
| 86 | activation of Rac GTPase activity (GO:0032863) | 2.50863041 |
| 87 | hyaluronan catabolic process (GO:0030214) | 2.50841432 |
| 88 | membrane protein ectodomain proteolysis (GO:0006509) | 2.50100138 |
| 89 | glucose 6-phosphate metabolic process (GO:0051156) | 2.49697272 |
| 90 | azole transport (GO:0045117) | 2.49369423 |
| 91 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.48374388 |
| 92 | endothelium development (GO:0003158) | 2.47982371 |
| 93 | folic acid metabolic process (GO:0046655) | 2.47062507 |
| 94 | proline metabolic process (GO:0006560) | 2.46974966 |
| 95 | urea metabolic process (GO:0019627) | 2.46418730 |
| 96 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.45592791 |
| 97 | cellular potassium ion homeostasis (GO:0030007) | 2.44733770 |
| 98 | very long-chain fatty acid metabolic process (GO:0000038) | 2.44724506 |
| 99 | regulation of chromatin binding (GO:0035561) | 2.44192126 |
| 100 | NADH metabolic process (GO:0006734) | 2.42710344 |
| 101 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.42446636 |
| 102 | histone arginine methylation (GO:0034969) | 2.42061975 |
| 103 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.41251303 |
| 104 | positive regulation of nuclease activity (GO:0032075) | 2.40787117 |
| 105 | ceramide catabolic process (GO:0046514) | 2.40681070 |
| 106 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.39193699 |
| 107 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.39037975 |
| 108 | adherens junction assembly (GO:0034333) | 2.38974591 |
| 109 | regulation of cardioblast differentiation (GO:0051890) | 2.38956575 |
| 110 | protein complex localization (GO:0031503) | 2.38781631 |
| 111 | formation of translation preinitiation complex (GO:0001731) | 2.37289710 |
| 112 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.36213970 |
| 113 | modulation by symbiont of host cellular process (GO:0044068) | 2.35613524 |
| 114 | negative regulation of viral release from host cell (GO:1902187) | 2.35499810 |
| 115 | apoptotic cell clearance (GO:0043277) | 2.35303289 |
| 116 | nucleotide salvage (GO:0043173) | 2.35117180 |
| 117 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.34870152 |
| 118 | positive regulation of B cell differentiation (GO:0045579) | 2.34512320 |
| 119 | oligosaccharide catabolic process (GO:0009313) | 2.33811801 |
| 120 | glucose catabolic process (GO:0006007) | 2.32749822 |
| 121 | adhesion of symbiont to host (GO:0044406) | 2.32338374 |
| 122 | negative T cell selection (GO:0043383) | 2.32310495 |
| 123 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.31751780 |
| 124 | monosaccharide biosynthetic process (GO:0046364) | 2.30721299 |
| 125 | muscle cell fate commitment (GO:0042693) | 2.30003020 |
| 126 | positive thymic T cell selection (GO:0045059) | 2.29669676 |
| 127 | NIK/NF-kappaB signaling (GO:0038061) | 2.28746893 |
| 128 | Peyers patch development (GO:0048541) | 2.28120709 |
| 129 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.28120709 |
| 130 | DNA unwinding involved in DNA replication (GO:0006268) | 2.28030651 |
| 131 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.27845947 |
| 132 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.27690428 |
| 133 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.27292483 |
| 134 | activation of MAPKKK activity (GO:0000185) | 2.27291767 |
| 135 | alpha-linolenic acid metabolic process (GO:0036109) | 2.27268428 |
| 136 | low-density lipoprotein particle clearance (GO:0034383) | 2.26826271 |
| 137 | protein insertion into membrane (GO:0051205) | 2.26697460 |
| 138 | mitotic G1/S transition checkpoint (GO:0044819) | 2.25806093 |
| 139 | maternal placenta development (GO:0001893) | 2.25034502 |
| 140 | receptor catabolic process (GO:0032801) | 2.24899886 |
| 141 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.24640175 |
| 142 | stress fiber assembly (GO:0043149) | 2.23646705 |
| 143 | 4-hydroxyproline metabolic process (GO:0019471) | 2.23459760 |
| 144 | mitotic chromosome condensation (GO:0007076) | 2.23387796 |
| 145 | modulation by virus of host process (GO:0019054) | 2.23093004 |
| 146 | NADP metabolic process (GO:0006739) | 2.22786882 |
| 147 | negative thymic T cell selection (GO:0045060) | 2.19184986 |
| 148 | sulfur amino acid catabolic process (GO:0000098) | 2.19115217 |
| 149 | endosome to melanosome transport (GO:0035646) | 2.17136205 |
| 150 | endosome to pigment granule transport (GO:0043485) | 2.17136205 |
| 151 | reverse cholesterol transport (GO:0043691) | 2.17087870 |
| 152 | negative regulation of type 2 immune response (GO:0002829) | 2.17073701 |
| 153 | response to interleukin-15 (GO:0070672) | 2.16124265 |
| 154 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.14816941 |
| 155 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.14508361 |
| 156 | regulation of actin nucleation (GO:0051125) | 2.14440790 |
| 157 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.14069837 |
| 158 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.12691939 |
| 159 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.11666122 |
| 160 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.11517543 |
| 161 | branched-chain amino acid metabolic process (GO:0009081) | 2.10728465 |
| 162 | high-density lipoprotein particle remodeling (GO:0034375) | 2.10000838 |
| 163 | regulation of defense response to virus by virus (GO:0050690) | 2.09778018 |
| 164 | lymph node development (GO:0048535) | 2.09256852 |
| 165 | alanine transport (GO:0032328) | 2.08501527 |
| 166 | cellular extravasation (GO:0045123) | 2.08062208 |
| 167 | platelet dense granule organization (GO:0060155) | 2.06507702 |
| 168 | positive regulation of insulin secretion (GO:0032024) | 2.06244615 |
| 169 | peroxisomal transport (GO:0043574) | 2.05730626 |
| 170 | megakaryocyte development (GO:0035855) | 2.05605965 |
| 171 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.05451984 |
| 172 | T cell receptor signaling pathway (GO:0050852) | 2.05399790 |
| 173 | thymic T cell selection (GO:0045061) | 2.05148884 |
| 174 | cellular modified amino acid catabolic process (GO:0042219) | 2.04396575 |
| 175 | mannosylation (GO:0097502) | 2.03651503 |
| 176 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.02944205 |
| 177 | cellular ketone body metabolic process (GO:0046950) | 2.02390117 |
| 178 | positive T cell selection (GO:0043368) | 2.02158564 |
| 179 | regulation of triglyceride metabolic process (GO:0090207) | 2.01238495 |
| 180 | peroxisome organization (GO:0007031) | 2.01191506 |
| 181 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.01090494 |
| 182 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.00962192 |
| 183 | protein retention in ER lumen (GO:0006621) | 2.00927971 |
| 184 | positive regulation of respiratory burst (GO:0060267) | 1.99473422 |
| 185 | regulation of respiratory burst (GO:0060263) | 1.99049631 |
| 186 | nucleoside diphosphate catabolic process (GO:0009134) | 1.97859001 |
| 187 | nitric oxide mediated signal transduction (GO:0007263) | 1.97683892 |
| 188 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 1.97474044 |
| 189 | regulation of regulatory T cell differentiation (GO:0045589) | 1.97321561 |
| 190 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 1.97227977 |
| 191 | fatty acid catabolic process (GO:0009062) | 1.97226592 |
| 192 | sodium ion export (GO:0071436) | 1.96918474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.48997840 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.37668343 |
| 3 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.86168071 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.77374355 |
| 5 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.75581102 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.66944441 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.64296959 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.49344264 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.45720162 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.33470255 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.28885550 |
| 12 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.19579061 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.17583107 |
| 14 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16209159 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.13701643 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.10993775 |
| 17 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.08235858 |
| 18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.04848011 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.02268094 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95510064 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.95288338 |
| 22 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94636552 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.93639547 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93455118 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.92871228 |
| 26 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.91501051 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91018162 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.85498441 |
| 29 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81222555 |
| 30 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.80029788 |
| 31 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.78820805 |
| 32 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.73765965 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72812914 |
| 34 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.67742712 |
| 35 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67254672 |
| 36 | GATA1_19941826_ChIP-Seq_K562_Human | 1.64949150 |
| 37 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.63655112 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63424356 |
| 39 | P68_20966046_ChIP-Seq_HELA_Human | 1.61884656 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.61620577 |
| 41 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.61474988 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.60724949 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60468766 |
| 44 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.59361212 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.58983347 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58794704 |
| 47 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56329242 |
| 48 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.53870154 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53675352 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52612844 |
| 51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51406520 |
| 52 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.50357381 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47404518 |
| 54 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.47391264 |
| 55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.46765647 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.46033551 |
| 57 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45629799 |
| 58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.44895113 |
| 59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44743321 |
| 60 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.43295643 |
| 61 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.41765618 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41614964 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41570920 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.41562481 |
| 65 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.40698793 |
| 66 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.40682892 |
| 67 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.40555663 |
| 68 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.39843570 |
| 69 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.37596816 |
| 70 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.37444955 |
| 71 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36965721 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36213124 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.36180050 |
| 74 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.35052354 |
| 75 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34612227 |
| 76 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33775219 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.33001796 |
| 78 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.32058931 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30297756 |
| 80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30042149 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29505214 |
| 82 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28606991 |
| 83 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.28569592 |
| 84 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27090067 |
| 85 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26974397 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26450420 |
| 87 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25857458 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.24949787 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24887635 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24256035 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24246784 |
| 92 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23905359 |
| 93 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22152424 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21460693 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21117500 |
| 96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.20976161 |
| 97 | MYB_26560356_Chip-Seq_TH2_Human | 1.20730497 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 1.20468268 |
| 99 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.19470562 |
| 100 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18853999 |
| 101 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18385935 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18305621 |
| 103 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.18258170 |
| 104 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.18026272 |
| 105 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17588130 |
| 106 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.17248939 |
| 107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16892767 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16737097 |
| 109 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.16657698 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16469600 |
| 111 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.14640553 |
| 112 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14527331 |
| 113 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14111484 |
| 114 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14056935 |
| 115 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.13968616 |
| 116 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.13647537 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13302643 |
| 118 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13194478 |
| 119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13164868 |
| 120 | MYB_26560356_Chip-Seq_TH1_Human | 1.12320050 |
| 121 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12275584 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12255970 |
| 123 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11788413 |
| 124 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.10587731 |
| 125 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10490874 |
| 126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10011570 |
| 127 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09660061 |
| 128 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08797899 |
| 129 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08488334 |
| 130 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08172975 |
| 131 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.06200505 |
| 132 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06188028 |
| 133 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06164021 |
| 134 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06160622 |
| 135 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.05218554 |
| 136 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05154057 |
| 137 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.03835534 |
| 138 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.02129002 |
| 139 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02127528 |
| 140 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.01717965 |
| 141 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01241897 |
| 142 | MAF_26560356_Chip-Seq_TH2_Human | 1.00231650 |
| 143 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.00124788 |
| 144 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.00080414 |
| 145 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.99195159 |
| 146 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98196015 |
| 147 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.97670625 |
| 148 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97224908 |
| 149 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95119618 |
| 150 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.94611202 |
| 151 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93555700 |
| 152 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.92849975 |
| 153 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92143510 |
| 154 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.92023603 |
| 155 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.91578867 |
| 156 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91183250 |
| 157 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90845722 |
| 158 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.89370642 |
| 159 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89083954 |
| 160 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88499437 |
| 161 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88463891 |
| 162 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.88402575 |
| 163 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.87002533 |
| 164 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.86899289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 4.05022736 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.09116570 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 2.93938094 |
| 4 | MP0005365_abnormal_bile_salt | 2.70689736 |
| 5 | MP0008260_abnormal_autophagy | 2.57613424 |
| 6 | MP0004185_abnormal_adipocyte_glucose | 2.39392167 |
| 7 | MP0004233_abnormal_muscle_weight | 2.39072068 |
| 8 | MP0000678_abnormal_parathyroid_gland | 2.33389237 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.32746299 |
| 10 | MP0000685_abnormal_immune_system | 2.28000015 |
| 11 | MP0005671_abnormal_response_to | 2.25307777 |
| 12 | MP0009333_abnormal_splenocyte_physiolog | 2.20420314 |
| 13 | MP0003724_increased_susceptibility_to | 2.12275292 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.09177588 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.09082200 |
| 16 | MP0003303_peritoneal_inflammation | 2.07433694 |
| 17 | MP0002796_impaired_skin_barrier | 2.04122445 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.04116950 |
| 19 | MP0005084_abnormal_gallbladder_morpholo | 2.03404220 |
| 20 | MP0003183_abnormal_peptide_metabolism | 2.01313437 |
| 21 | MP0001873_stomach_inflammation | 2.01164175 |
| 22 | MP0000013_abnormal_adipose_tissue | 2.00690771 |
| 23 | MP0008961_abnormal_basal_metabolism | 1.97340322 |
| 24 | MP0005075_abnormal_melanosome_morpholog | 1.93890335 |
| 25 | MP0002693_abnormal_pancreas_physiology | 1.93386432 |
| 26 | MP0003453_abnormal_keratinocyte_physiol | 1.91920252 |
| 27 | MP0003866_abnormal_defecation | 1.91497585 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.90130766 |
| 29 | MP0009840_abnormal_foam_cell | 1.84913647 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.80641883 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.78507461 |
| 32 | MP0000681_abnormal_thyroid_gland | 1.76034692 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.74060635 |
| 34 | MP0009278_abnormal_bone_marrow | 1.69857037 |
| 35 | MP0004147_increased_porphyrin_level | 1.68561045 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.67516741 |
| 37 | MP0010329_abnormal_lipoprotein_level | 1.66066125 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.64864009 |
| 39 | MP0003329_amyloid_beta_deposits | 1.64544455 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.64032484 |
| 41 | MP0005220_abnormal_exocrine_pancreas | 1.61714108 |
| 42 | MP0004859_abnormal_synaptic_plasticity | 1.59226976 |
| 43 | MP0005360_urolithiasis | 1.56749083 |
| 44 | MP0005501_abnormal_skin_physiology | 1.53719307 |
| 45 | MP0005387_immune_system_phenotype | 1.52776547 |
| 46 | MP0001790_abnormal_immune_system | 1.52776547 |
| 47 | MP0001944_abnormal_pancreas_morphology | 1.50544970 |
| 48 | MP0001800_abnormal_humoral_immune | 1.49827235 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.48819106 |
| 50 | MP0004858_abnormal_nervous_system | 1.47910807 |
| 51 | MP0000537_abnormal_urethra_morphology | 1.47336538 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.44667171 |
| 53 | MP0001849_ear_inflammation | 1.43304307 |
| 54 | MP0002249_abnormal_larynx_morphology | 1.40112269 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.39173056 |
| 56 | MP0004947_skin_inflammation | 1.39045298 |
| 57 | MP0002723_abnormal_immune_serum | 1.37578819 |
| 58 | MP0003880_abnormal_central_pattern | 1.36551586 |
| 59 | MP0005670_abnormal_white_adipose | 1.36253034 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.34890798 |
| 61 | MP0005025_abnormal_response_to | 1.34751789 |
| 62 | MP0002090_abnormal_vision | 1.34525594 |
| 63 | MP0000015_abnormal_ear_pigmentation | 1.33979883 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.32250755 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.32246873 |
| 66 | MP0005085_abnormal_gallbladder_physiolo | 1.31428391 |
| 67 | MP0009785_altered_susceptibility_to | 1.30892135 |
| 68 | MP0003075_altered_response_to | 1.30270636 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 1.30267374 |
| 70 | MP0001819_abnormal_immune_cell | 1.29263994 |
| 71 | MP0001501_abnormal_sleep_pattern | 1.28984604 |
| 72 | MP0005000_abnormal_immune_tolerance | 1.26536732 |
| 73 | MP0002928_abnormal_bile_duct | 1.26257155 |
| 74 | MP0003172_abnormal_lysosome_physiology | 1.25635844 |
| 75 | MP0002452_abnormal_antigen_presenting | 1.25296597 |
| 76 | MP0005310_abnormal_salivary_gland | 1.24097824 |
| 77 | MP0008004_abnormal_stomach_pH | 1.23406152 |
| 78 | MP0001664_abnormal_digestion | 1.23020561 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 1.22560589 |
| 80 | MP0000858_altered_metastatic_potential | 1.22166028 |
| 81 | MP0003635_abnormal_synaptic_transmissio | 1.22000255 |
| 82 | MP0000609_abnormal_liver_physiology | 1.21112254 |
| 83 | MP0002118_abnormal_lipid_homeostasis | 1.21022003 |
| 84 | MP0002398_abnormal_bone_marrow | 1.20995945 |
| 85 | MP0002078_abnormal_glucose_homeostasis | 1.19862711 |
| 86 | MP0000604_amyloidosis | 1.19650568 |
| 87 | MP0002822_catalepsy | 1.17126867 |
| 88 | MP0000733_abnormal_muscle_development | 1.16982623 |
| 89 | MP0009643_abnormal_urine_homeostasis | 1.16008175 |
| 90 | MP0001666_abnormal_nutrient_absorption | 1.15825657 |
| 91 | MP0003436_decreased_susceptibility_to | 1.15601750 |
| 92 | MP0006276_abnormal_autonomic_nervous | 1.15028559 |
| 93 | MP0000003_abnormal_adipose_tissue | 1.14757434 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 1.14092000 |
| 95 | MP0003111_abnormal_nucleus_morphology | 1.13834904 |
| 96 | MP0002638_abnormal_pupillary_reflex | 1.11407817 |
| 97 | MP0003693_abnormal_embryo_hatching | 1.11202064 |
| 98 | MP0004264_abnormal_extraembryonic_tissu | 1.09952637 |
| 99 | MP0003634_abnormal_glial_cell | 1.09277065 |
| 100 | MP0003633_abnormal_nervous_system | 1.08185794 |
| 101 | MP0005623_abnormal_meninges_morphology | 1.08005501 |
| 102 | MP0010386_abnormal_urinary_bladder | 1.07754050 |
| 103 | MP0003300_gastrointestinal_ulcer | 1.06941165 |
| 104 | MP0004381_abnormal_hair_follicle | 1.05721206 |
| 105 | MP0003806_abnormal_nucleotide_metabolis | 1.05689695 |
| 106 | MP0002419_abnormal_innate_immunity | 1.04986765 |
| 107 | MP0001502_abnormal_circadian_rhythm | 1.04798545 |
| 108 | MP0001845_abnormal_inflammatory_respons | 1.03103131 |
| 109 | MP0005535_abnormal_body_temperature | 1.02843969 |
| 110 | MP0000716_abnormal_immune_system | 1.02097390 |
| 111 | MP0008569_lethality_at_weaning | 1.01580713 |
| 112 | MP0001853_heart_inflammation | 1.00361732 |
| 113 | MP0003191_abnormal_cellular_cholesterol | 0.99969218 |
| 114 | MP0003123_paternal_imprinting | 0.98890647 |
| 115 | MP0001661_extended_life_span | 0.98464408 |
| 116 | MP0006054_spinal_hemorrhage | 0.98440112 |
| 117 | MP0009764_decreased_sensitivity_to | 0.98332019 |
| 118 | MP0003879_abnormal_hair_cell | 0.97643696 |
| 119 | MP0008469_abnormal_protein_level | 0.97326068 |
| 120 | MP0001216_abnormal_epidermal_layer | 0.97317069 |
| 121 | MP0002837_dystrophic_cardiac_calcinosis | 0.97005983 |
| 122 | MP0005409_darkened_coat_color | 0.96837548 |
| 123 | MP0002877_abnormal_melanocyte_morpholog | 0.96443305 |
| 124 | MP0000490_abnormal_crypts_of | 0.96435164 |
| 125 | MP0001545_abnormal_hematopoietic_system | 0.96390388 |
| 126 | MP0005397_hematopoietic_system_phenotyp | 0.96390388 |
| 127 | MP0010155_abnormal_intestine_physiology | 0.95852358 |
| 128 | MP0005334_abnormal_fat_pad | 0.95688044 |
| 129 | MP0001346_abnormal_lacrimal_gland | 0.95238525 |
| 130 | MP0010307_abnormal_tumor_latency | 0.94586048 |
| 131 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94145458 |
| 132 | MP0003868_abnormal_feces_composition | 0.94026928 |
| 133 | MP0005332_abnormal_amino_acid | 0.93785789 |
| 134 | MP0002429_abnormal_blood_cell | 0.92570295 |
| 135 | MP0002009_preneoplasia | 0.92408807 |
| 136 | MP0002736_abnormal_nociception_after | 0.91706381 |
| 137 | MP0000747_muscle_weakness | 0.91597544 |
| 138 | MP0000689_abnormal_spleen_morphology | 0.91552832 |
| 139 | MP0002098_abnormal_vibrissa_morphology | 0.91502413 |
| 140 | MP0009745_abnormal_behavioral_response | 0.91469629 |
| 141 | MP0002064_seizures | 0.91279791 |
| 142 | MP0004510_myositis | 0.90459686 |
| 143 | MP0005166_decreased_susceptibility_to | 0.90310993 |
| 144 | MP0002272_abnormal_nervous_system | 0.89219761 |
| 145 | MP0002006_tumorigenesis | 0.89156873 |
| 146 | MP0001270_distended_abdomen | 0.89080369 |
| 147 | MP0009765_abnormal_xenobiotic_induced | 0.88834402 |
| 148 | MP0000313_abnormal_cell_death | 0.88811374 |
| 149 | MP0001730_embryonic_growth_arrest | 0.88211460 |
| 150 | MP0000343_altered_response_to | 0.87889264 |
| 151 | MP0000350_abnormal_cell_proliferation | 0.87130701 |
| 152 | MP0002132_abnormal_respiratory_system | 0.86524177 |
| 153 | MP0003077_abnormal_cell_cycle | 0.84631545 |
| 154 | MP0003566_abnormal_cell_adhesion | 0.82762140 |
| 155 | MP0002148_abnormal_hypersensitivity_rea | 0.81947535 |
| 156 | MP0002998_abnormal_bone_remodeling | 0.81549112 |
| 157 | MP0009053_abnormal_anal_canal | 0.81087704 |
| 158 | MP0009931_abnormal_skin_appearance | 0.78304890 |
| 159 | MP0003315_abnormal_perineum_morphology | 0.77178453 |
| 160 | MP0005621_abnormal_cell_physiology | 0.76402337 |
| 161 | MP0006082_CNS_inflammation | 0.75475390 |
| 162 | MP0002060_abnormal_skin_morphology | 0.73654985 |
| 163 | MP0002234_abnormal_pharynx_morphology | 0.72947417 |
| 164 | MP0010352_gastrointestinal_tract_polyps | 0.72673941 |
| 165 | MP0003091_abnormal_cell_migration | 0.72448856 |
| 166 | MP0001881_abnormal_mammary_gland | 0.69721053 |
| 167 | MP0001727_abnormal_embryo_implantation | 0.67850092 |
| 168 | MP0004957_abnormal_blastocyst_morpholog | 0.66412514 |
| 169 | MP0001348_abnormal_lacrimal_gland | 0.64272814 |
| 170 | MP0008874_decreased_physiological_sensi | 0.61841843 |
| 171 | MP0000703_abnormal_thymus_morphology | 0.61349882 |
| 172 | MP0002089_abnormal_postnatal_growth/wei | 0.61173589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mutism (HP:0002300) | 4.98821558 |
| 2 | Hypoglycemic coma (HP:0001325) | 3.82746298 |
| 3 | Hypoglycemic seizures (HP:0002173) | 3.64090190 |
| 4 | Symptomatic seizures (HP:0011145) | 3.56094506 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.47619045 |
| 6 | Ketosis (HP:0001946) | 3.22976621 |
| 7 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.12697332 |
| 8 | Growth hormone excess (HP:0000845) | 3.10627874 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 3.07581105 |
| 10 | Ketoacidosis (HP:0001993) | 3.04108832 |
| 11 | Chronic otitis media (HP:0000389) | 3.04074626 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.01077785 |
| 13 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.98335013 |
| 14 | Generalized aminoaciduria (HP:0002909) | 2.90924632 |
| 15 | Ragged-red muscle fibers (HP:0003200) | 2.79806277 |
| 16 | Broad distal phalanx of finger (HP:0009836) | 2.76560650 |
| 17 | Congenital malformation of the right heart (HP:0011723) | 2.75980871 |
| 18 | Double outlet right ventricle (HP:0001719) | 2.75980871 |
| 19 | Truncus arteriosus (HP:0001660) | 2.73931357 |
| 20 | Hyperacusis (HP:0010780) | 2.72410860 |
| 21 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.70740474 |
| 22 | Vertebral compression fractures (HP:0002953) | 2.70152493 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.63360826 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.63360826 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.63360826 |
| 26 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.62755545 |
| 27 | Prolonged bleeding time (HP:0003010) | 2.59830652 |
| 28 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.59678988 |
| 29 | Achilles tendon contracture (HP:0001771) | 2.59522676 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55222724 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 2.53644935 |
| 32 | Paraparesis (HP:0002385) | 2.52879112 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.52776097 |
| 34 | Mucopolysacchariduria (HP:0008155) | 2.52776097 |
| 35 | Neurofibrillary tangles (HP:0002185) | 2.52171696 |
| 36 | Progressive muscle weakness (HP:0003323) | 2.48918402 |
| 37 | Purpura (HP:0000979) | 2.45292905 |
| 38 | Confusion (HP:0001289) | 2.44859470 |
| 39 | Prolonged neonatal jaundice (HP:0006579) | 2.43474501 |
| 40 | Hepatic necrosis (HP:0002605) | 2.42641524 |
| 41 | Supranuclear gaze palsy (HP:0000605) | 2.42330893 |
| 42 | Type II lissencephaly (HP:0007260) | 2.41969342 |
| 43 | Recurrent abscess formation (HP:0002722) | 2.41343365 |
| 44 | Progressive neurologic deterioration (HP:0002344) | 2.40273765 |
| 45 | Inability to walk (HP:0002540) | 2.38862368 |
| 46 | Xanthomatosis (HP:0000991) | 2.36564935 |
| 47 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.34221379 |
| 48 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.34221379 |
| 49 | Neuronal loss in central nervous system (HP:0002529) | 2.33515735 |
| 50 | Hypothermia (HP:0002045) | 2.32904653 |
| 51 | Microvesicular hepatic steatosis (HP:0001414) | 2.31463804 |
| 52 | Abnormality of the thoracic spine (HP:0100711) | 2.31292058 |
| 53 | Hepatocellular necrosis (HP:0001404) | 2.31182900 |
| 54 | Abnormality of the Achilles tendon (HP:0005109) | 2.30670363 |
| 55 | Axonal loss (HP:0003447) | 2.29306943 |
| 56 | Stridor (HP:0010307) | 2.27591527 |
| 57 | Epistaxis (HP:0000421) | 2.27017431 |
| 58 | Agitation (HP:0000713) | 2.26626402 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.26555475 |
| 60 | Transposition of the great arteries (HP:0001669) | 2.25318109 |
| 61 | Abnormal connection of the cardiac segments (HP:0011545) | 2.25318109 |
| 62 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.25318109 |
| 63 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.24650465 |
| 64 | Recurrent bronchitis (HP:0002837) | 2.23396790 |
| 65 | Hypertensive crisis (HP:0100735) | 2.22809238 |
| 66 | Papilledema (HP:0001085) | 2.22739690 |
| 67 | J-shaped sella turcica (HP:0002680) | 2.21565943 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.21555335 |
| 69 | Thoracic kyphosis (HP:0002942) | 2.20525608 |
| 70 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.20464833 |
| 71 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.20464833 |
| 72 | Abnormal protein glycosylation (HP:0012346) | 2.20464833 |
| 73 | Abnormal glycosylation (HP:0012345) | 2.20464833 |
| 74 | Gingival bleeding (HP:0000225) | 2.20325825 |
| 75 | Hyperthyroidism (HP:0000836) | 2.19632612 |
| 76 | Systemic lupus erythematosus (HP:0002725) | 2.19347525 |
| 77 | Bulbar palsy (HP:0001283) | 2.19157097 |
| 78 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.18136781 |
| 79 | Increased IgE level (HP:0003212) | 2.15080977 |
| 80 | Severe visual impairment (HP:0001141) | 2.13586699 |
| 81 | Fatigue (HP:0012378) | 2.13268742 |
| 82 | Colitis (HP:0002583) | 2.10547099 |
| 83 | Hypokinesia (HP:0002375) | 2.10423478 |
| 84 | Menstrual irregularities (HP:0000858) | 2.09037744 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.08227895 |
| 86 | Vacuolated lymphocytes (HP:0001922) | 2.07281470 |
| 87 | Hyperparathyroidism (HP:0000843) | 2.06165745 |
| 88 | Loss of speech (HP:0002371) | 2.05768355 |
| 89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.05297489 |
| 90 | Thin bony cortex (HP:0002753) | 2.05021683 |
| 91 | Upper motor neuron abnormality (HP:0002127) | 2.04320739 |
| 92 | Craniofacial dystonia (HP:0012179) | 2.03647103 |
| 93 | Delayed CNS myelination (HP:0002188) | 2.03159770 |
| 94 | Torticollis (HP:0000473) | 2.02932840 |
| 95 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.01535500 |
| 96 | Anxiety (HP:0000739) | 2.01482343 |
| 97 | Eczematoid dermatitis (HP:0000976) | 2.01177986 |
| 98 | Late onset (HP:0003584) | 2.01143182 |
| 99 | Interstitial pulmonary disease (HP:0006530) | 2.00217054 |
| 100 | Myositis (HP:0100614) | 1.98104276 |
| 101 | Large eyes (HP:0001090) | 1.98102894 |
| 102 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.97892964 |
| 103 | Abnormality of macrophages (HP:0004311) | 1.97776583 |
| 104 | Cholecystitis (HP:0001082) | 1.97480327 |
| 105 | Abnormal gallbladder physiology (HP:0012438) | 1.97480327 |
| 106 | Spinal canal stenosis (HP:0003416) | 1.96024223 |
| 107 | Psychosis (HP:0000709) | 1.95903146 |
| 108 | Retinal dysplasia (HP:0007973) | 1.95759230 |
| 109 | Insomnia (HP:0100785) | 1.95142419 |
| 110 | Nasal polyposis (HP:0100582) | 1.95119844 |
| 111 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.94714639 |
| 112 | Menorrhagia (HP:0000132) | 1.94669560 |
| 113 | Impaired platelet aggregation (HP:0003540) | 1.94010588 |
| 114 | Abnormal platelet function (HP:0011869) | 1.94010588 |
| 115 | Focal dystonia (HP:0004373) | 1.93836646 |
| 116 | Rigidity (HP:0002063) | 1.93315553 |
| 117 | Chronic sinusitis (HP:0011109) | 1.93203950 |
| 118 | Ulnar bowing (HP:0003031) | 1.92525909 |
| 119 | Generalized hyperpigmentation (HP:0007440) | 1.92349494 |
| 120 | Joint swelling (HP:0001386) | 1.92146733 |
| 121 | Thrombocytosis (HP:0001894) | 1.90671077 |
| 122 | Cerebral inclusion bodies (HP:0100314) | 1.90659615 |
| 123 | Abnormality of the nasal mucosa (HP:0000433) | 1.89104455 |
| 124 | Testicular atrophy (HP:0000029) | 1.87582759 |
| 125 | Short nail (HP:0001799) | 1.87575177 |
| 126 | Large for gestational age (HP:0001520) | 1.86255079 |
| 127 | Polygenic inheritance (HP:0010982) | 1.84684042 |
| 128 | Abnormality of glycolipid metabolism (HP:0010969) | 1.84497989 |
| 129 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.84497989 |
| 130 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.84497989 |
| 131 | Retinal atrophy (HP:0001105) | 1.84329572 |
| 132 | Cardiomegaly (HP:0001640) | 1.84084799 |
| 133 | Brushfield spots (HP:0001088) | 1.83673353 |
| 134 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.82953256 |
| 135 | Dementia (HP:0000726) | 1.82607946 |
| 136 | Septate vagina (HP:0001153) | 1.82598128 |
| 137 | Severe muscular hypotonia (HP:0006829) | 1.82327378 |
| 138 | Progressive inability to walk (HP:0002505) | 1.81935976 |
| 139 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.81920570 |
| 140 | Hyperbilirubinemia (HP:0002904) | 1.81731312 |
| 141 | Hypercortisolism (HP:0001578) | 1.81476491 |
| 142 | Trismus (HP:0000211) | 1.81388247 |
| 143 | Unilateral renal agenesis (HP:0000122) | 1.80799126 |
| 144 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.80455829 |
| 145 | Limb dystonia (HP:0002451) | 1.80213947 |
| 146 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.80209522 |
| 147 | Hypoplastic left heart (HP:0004383) | 1.80017891 |
| 148 | Abnormality of the umbilical cord (HP:0010881) | 1.79981019 |
| 149 | Microretrognathia (HP:0000308) | 1.79819935 |
| 150 | Seborrheic dermatitis (HP:0001051) | 1.79675203 |
| 151 | Bone pain (HP:0002653) | 1.78069164 |
| 152 | Flat acetabular roof (HP:0003180) | 1.77838760 |
| 153 | Increased serum ferritin (HP:0003281) | 1.77044346 |
| 154 | Depression (HP:0000716) | 1.75882700 |
| 155 | Personality changes (HP:0000751) | 1.75686786 |
| 156 | Decreased circulating renin level (HP:0003351) | 1.75665130 |
| 157 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.75164462 |
| 158 | Single umbilical artery (HP:0001195) | 1.75164462 |
| 159 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.75164462 |
| 160 | IgM deficiency (HP:0002850) | 1.74597037 |
| 161 | Gastrointestinal stroma tumor (HP:0100723) | 1.74420864 |
| 162 | Abnormality of the gallbladder (HP:0005264) | 1.74297950 |
| 163 | Panhypogammaglobulinemia (HP:0003139) | 1.73936159 |
| 164 | Hypoplasia of the thymus (HP:0000778) | 1.73538626 |
| 165 | Premature skin wrinkling (HP:0100678) | 1.73107262 |
| 166 | Nuclear cataract (HP:0100018) | 1.72629785 |
| 167 | Cerebral aneurysm (HP:0004944) | 1.72181185 |
| 168 | Upper limb amyotrophy (HP:0009129) | 1.71162638 |
| 169 | Distal upper limb amyotrophy (HP:0007149) | 1.71162638 |
| 170 | Short clavicles (HP:0000894) | 1.70583212 |
| 171 | Abnormal large intestine physiology (HP:0012700) | 1.70460244 |
| 172 | Amyloidosis (HP:0011034) | 1.70208193 |
| 173 | Agammaglobulinemia (HP:0004432) | 1.70168924 |
| 174 | Spinal cord compression (HP:0002176) | 1.70122953 |
| 175 | Myopathic facies (HP:0002058) | 1.69842505 |
| 176 | Germ cell neoplasia (HP:0100728) | 1.68758245 |
| 177 | Sparse lateral eyebrow (HP:0005338) | 1.68178175 |
| 178 | Abnormality of carpal bone ossification (HP:0006257) | 1.66960023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.57150752 |
| 2 | SMG1 | 4.41913414 |
| 3 | NME2 | 4.04759425 |
| 4 | BCKDK | 3.94590664 |
| 5 | MAP4K1 | 3.62328423 |
| 6 | ERN1 | 3.15033221 |
| 7 | MAP3K12 | 2.96852913 |
| 8 | IRAK3 | 2.52005114 |
| 9 | ICK | 2.44425099 |
| 10 | SIK1 | 2.37027518 |
| 11 | KIT | 2.34031695 |
| 12 | PRKD3 | 2.22989830 |
| 13 | TBK1 | 2.13315347 |
| 14 | PKN2 | 1.89487303 |
| 15 | ZAP70 | 1.87418411 |
| 16 | CDK19 | 1.84946192 |
| 17 | MAPK15 | 1.83853344 |
| 18 | IKBKE | 1.78157172 |
| 19 | ARAF | 1.76654656 |
| 20 | TAOK3 | 1.73330111 |
| 21 | CAMK1D | 1.68473172 |
| 22 | TXK | 1.67717527 |
| 23 | EEF2K | 1.66437334 |
| 24 | FGFR4 | 1.59208737 |
| 25 | FLT3 | 1.54456555 |
| 26 | SIK3 | 1.51892256 |
| 27 | MAP3K3 | 1.51688187 |
| 28 | MAP2K3 | 1.50620899 |
| 29 | CAMKK2 | 1.48157917 |
| 30 | ITK | 1.48093142 |
| 31 | TYK2 | 1.47131471 |
| 32 | JAK3 | 1.44326045 |
| 33 | CDK12 | 1.43782263 |
| 34 | TNIK | 1.38168975 |
| 35 | TAOK1 | 1.36680274 |
| 36 | SIK2 | 1.35948662 |
| 37 | CSF1R | 1.32473505 |
| 38 | TESK1 | 1.31489566 |
| 39 | SCYL2 | 1.29395855 |
| 40 | MAP3K13 | 1.28090241 |
| 41 | GRK6 | 1.26672712 |
| 42 | SYK | 1.26174947 |
| 43 | JAK1 | 1.24746976 |
| 44 | IRAK4 | 1.23007988 |
| 45 | MAPK12 | 1.21221342 |
| 46 | PDPK1 | 1.20208123 |
| 47 | MAP2K7 | 1.16279814 |
| 48 | TRIB3 | 1.16094545 |
| 49 | EPHA2 | 1.15952028 |
| 50 | RIPK4 | 1.15304669 |
| 51 | CAMK1G | 1.13802986 |
| 52 | MAPK11 | 1.13478728 |
| 53 | BRAF | 1.11857457 |
| 54 | HIPK2 | 1.11602924 |
| 55 | MAP3K14 | 1.11104188 |
| 56 | DYRK3 | 1.09891511 |
| 57 | KSR2 | 1.07254644 |
| 58 | VRK2 | 1.06784068 |
| 59 | BTK | 1.04110363 |
| 60 | EPHA4 | 1.03998359 |
| 61 | MAPKAPK3 | 1.03069355 |
| 62 | IRAK2 | 1.02691986 |
| 63 | PRKCH | 1.01743359 |
| 64 | ILK | 1.01696722 |
| 65 | MAPK7 | 1.01251013 |
| 66 | MAP2K2 | 1.01142342 |
| 67 | IRAK1 | 1.00674775 |
| 68 | PIM2 | 1.00477281 |
| 69 | FES | 0.97977876 |
| 70 | RIPK1 | 0.93436474 |
| 71 | ABL2 | 0.91581001 |
| 72 | KDR | 0.89811063 |
| 73 | TESK2 | 0.89728277 |
| 74 | LCK | 0.87037792 |
| 75 | MAP3K10 | 0.86678778 |
| 76 | PIK3CG | 0.85772380 |
| 77 | CDK7 | 0.84165165 |
| 78 | AURKA | 0.78894494 |
| 79 | MAPKAPK5 | 0.76600923 |
| 80 | TEC | 0.73687278 |
| 81 | MARK2 | 0.73640138 |
| 82 | RPS6KC1 | 0.73082893 |
| 83 | RPS6KL1 | 0.73082893 |
| 84 | MST1R | 0.72481974 |
| 85 | PTK6 | 0.72244201 |
| 86 | PAK4 | 0.70871883 |
| 87 | MAP3K8 | 0.70767546 |
| 88 | MTOR | 0.70590521 |
| 89 | CDK4 | 0.70119746 |
| 90 | MYLK | 0.70063499 |
| 91 | TGFBR2 | 0.70043451 |
| 92 | LYN | 0.69138822 |
| 93 | TAOK2 | 0.68892353 |
| 94 | PASK | 0.68850081 |
| 95 | NLK | 0.67625458 |
| 96 | DAPK3 | 0.66717017 |
| 97 | UHMK1 | 0.65941672 |
| 98 | TAF1 | 0.64488815 |
| 99 | MAP3K2 | 0.63341761 |
| 100 | RPS6KB2 | 0.62507088 |
| 101 | CDK8 | 0.61858486 |
| 102 | LRRK2 | 0.57863523 |
| 103 | CHEK2 | 0.57198024 |
| 104 | MAPK4 | 0.56800906 |
| 105 | DAPK1 | 0.56665259 |
| 106 | PRKG2 | 0.56253016 |
| 107 | HCK | 0.56114190 |
| 108 | MAP3K9 | 0.55933508 |
| 109 | MAP3K7 | 0.54668189 |
| 110 | MAP2K4 | 0.54474333 |
| 111 | CDK5 | 0.52503430 |
| 112 | PDK2 | 0.51744415 |
| 113 | AKT2 | 0.51686251 |
| 114 | MAP3K1 | 0.51027367 |
| 115 | TNK2 | 0.50370184 |
| 116 | PRKCI | 0.50179370 |
| 117 | RET | 0.48475313 |
| 118 | RPS6KA6 | 0.48229317 |
| 119 | JAK2 | 0.47832252 |
| 120 | PAK3 | 0.47016284 |
| 121 | BRSK1 | 0.46505863 |
| 122 | TTN | 0.46120823 |
| 123 | NTRK1 | 0.43856043 |
| 124 | CAMKK1 | 0.43308193 |
| 125 | PRPF4B | 0.42490714 |
| 126 | NTRK2 | 0.42333832 |
| 127 | CDK9 | 0.42290257 |
| 128 | MATK | 0.41450500 |
| 129 | TIE1 | 0.41053138 |
| 130 | BMX | 0.40867645 |
| 131 | CSNK1G3 | 0.40691747 |
| 132 | NTRK3 | 0.40556229 |
| 133 | MAP3K6 | 0.39699500 |
| 134 | TLK1 | 0.39381972 |
| 135 | RPS6KA2 | 0.38146238 |
| 136 | EPHB1 | 0.38047193 |
| 137 | PRKD2 | 0.38034035 |
| 138 | CDK6 | 0.37859646 |
| 139 | IKBKB | 0.37282290 |
| 140 | BLK | 0.35989185 |
| 141 | PDK1 | 0.35984427 |
| 142 | LATS2 | 0.34655427 |
| 143 | MELK | 0.34536702 |
| 144 | DYRK1B | 0.33565931 |
| 145 | CHUK | 0.33069066 |
| 146 | CDC42BPA | 0.32947029 |
| 147 | RPS6KA1 | 0.31985611 |
| 148 | PTK2 | 0.31976754 |
| 149 | MAP2K6 | 0.31364069 |
| 150 | FYN | 0.31171728 |
| 151 | MUSK | 0.30771158 |
| 152 | MAP3K11 | 0.29983067 |
| 153 | PHKG1 | 0.29844392 |
| 154 | PHKG2 | 0.29844392 |
| 155 | MINK1 | 0.29677734 |
| 156 | STK16 | 0.29588078 |
| 157 | DDR2 | 0.28889969 |
| 158 | LMTK2 | 0.27178222 |
| 159 | CLK1 | 0.26939025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.70604106 |
| 2 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.61375506 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.51343574 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.23261807 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.12864011 |
| 6 | Insulin secretion_Homo sapiens_hsa04911 | 1.95047392 |
| 7 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.94908448 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.93076388 |
| 9 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.90608107 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.87644643 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.82781432 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.81938654 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.81759744 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.79383341 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79334724 |
| 16 | Bladder cancer_Homo sapiens_hsa05219 | 1.71456253 |
| 17 | ABC transporters_Homo sapiens_hsa02010 | 1.71138020 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.67209558 |
| 19 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.66969598 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.66020262 |
| 21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.65243566 |
| 22 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.59835159 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.58479483 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.56827258 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.54175591 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.53168011 |
| 27 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.50696057 |
| 28 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.50541323 |
| 29 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.48993339 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48921537 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.47172950 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.46625392 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.45197580 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.45042457 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41945220 |
| 36 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.39374367 |
| 37 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.36164291 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.35223413 |
| 39 | Base excision repair_Homo sapiens_hsa03410 | 1.32455758 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31505038 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.26939857 |
| 42 | Endometrial cancer_Homo sapiens_hsa05213 | 1.24093993 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.23742550 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22005771 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21677419 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.19853756 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18983054 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.18829244 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.18375076 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.18214972 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16946792 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 1.16866333 |
| 53 | Glioma_Homo sapiens_hsa05214 | 1.16470638 |
| 54 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.15794242 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.15783858 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.14806452 |
| 57 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13910480 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09430238 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07333598 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.04850465 |
| 61 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.04722929 |
| 62 | Circadian entrainment_Homo sapiens_hsa04713 | 1.03053617 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01733995 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 1.01486623 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01116577 |
| 66 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.00841356 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.00128692 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00050278 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99125013 |
| 70 | GABAergic synapse_Homo sapiens_hsa04727 | 0.98549383 |
| 71 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.98504204 |
| 72 | Ribosome_Homo sapiens_hsa03010 | 0.98339784 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.97647016 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97403179 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96020946 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.94290595 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91565557 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88125471 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.87767307 |
| 80 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87449303 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.87105775 |
| 82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86642298 |
| 83 | Morphine addiction_Homo sapiens_hsa05032 | 0.84953419 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84833515 |
| 85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84366198 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84084290 |
| 87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.83571794 |
| 88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83181547 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.82246430 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.81799563 |
| 91 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81279056 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80935678 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80890410 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80611379 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.80106044 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79472253 |
| 97 | Hepatitis B_Homo sapiens_hsa05161 | 0.79443167 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78530718 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78423098 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78414308 |
| 101 | Salivary secretion_Homo sapiens_hsa04970 | 0.75995255 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.75987979 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74954326 |
| 104 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73712717 |
| 105 | Taste transduction_Homo sapiens_hsa04742 | 0.72478455 |
| 106 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72222969 |
| 107 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.71032978 |
| 108 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70664091 |
| 109 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70492960 |
| 110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69989153 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69719176 |
| 112 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69456815 |
| 113 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.68944675 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68732414 |
| 115 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.68082619 |
| 116 | Renin secretion_Homo sapiens_hsa04924 | 0.67815484 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.67437886 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67393511 |
| 119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67386071 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67018316 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66992135 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65696598 |
| 123 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65157408 |
| 124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64958186 |
| 125 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63747185 |
| 126 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.63737742 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62974236 |
| 128 | Influenza A_Homo sapiens_hsa05164 | 0.62603061 |
| 129 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62452916 |
| 130 | Shigellosis_Homo sapiens_hsa05131 | 0.61847929 |
| 131 | Alcoholism_Homo sapiens_hsa05034 | 0.61820600 |
| 132 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.61741262 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.60825396 |
| 134 | Phagosome_Homo sapiens_hsa04145 | 0.59737598 |
| 135 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.59192533 |
| 136 | Prostate cancer_Homo sapiens_hsa05215 | 0.58960173 |
| 137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58154985 |
| 138 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57574258 |
| 139 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.56816482 |
| 140 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55483140 |
| 141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55061262 |
| 142 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54804910 |
| 143 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54522417 |
| 144 | Salmonella infection_Homo sapiens_hsa05132 | 0.54079080 |
| 145 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53381360 |
| 146 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53147750 |
| 147 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52920974 |
| 148 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52750640 |
| 149 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52345051 |
| 150 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51338652 |
| 151 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51149071 |
| 152 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50879904 |
| 153 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50854330 |
| 154 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50015221 |
| 155 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49831959 |
| 156 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49765509 |
| 157 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49749128 |
| 158 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49240070 |
| 159 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48486666 |
| 160 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46183716 |
| 161 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46099309 |
| 162 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45931426 |
| 163 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44711107 |
| 164 | Measles_Homo sapiens_hsa05162 | 0.44522327 |
| 165 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43805521 |
| 166 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43251655 |
| 167 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42212664 |
| 168 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41585458 |
| 169 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40922592 |
| 170 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38435329 |
| 171 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38334178 |
| 172 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38213900 |
| 173 | Long-term potentiation_Homo sapiens_hsa04720 | 0.38205106 |

